Katarina Niward - Publications

Adaptation of the molecular bacterial load assay for real-time quantification of Mycobacterium tuberculosis in the clinical routine laboratory.

Journal: Microbiology spectrum

Published: August 18, 2026

Computer-aided detection of chest X-ray as a surrogate marker for disease severity in pulmonary TB.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: March 28, 2026

COVID-19 Mortality in Swedish Intensive Care Units: A Multicenter Survival Analysis.

Journal: Acta anaesthesiologica Scandinavica

Published: December 29, 2025

Future Prospects for Using Clinical Phenotypes in Tuberculosis Precision Medicine-An Approach for Clinical Management.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: September 08, 2025

60-day mortality and the role of SARS-CoV-2 in hospital admissions of immunocompromised patients during later Omicron period: a population-based study in Sweden.

Journal: Infectious diseases (London, England)

Published: February 16, 2025

Second-line antituberculosis drug exposure thresholds predictive of adverse events in multidrug-resistant tuberculosis treatment.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: October 26, 2023

Cognitive dysfunction in post-COVID-19 condition: Mechanisms, management, and rehabilitation.

Journal: Journal of internal medicine

Published: September 28, 2023

Risk factors for ventilator-associated lower respiratory tract infection in COVID-19, a retrospective multicenter cohort study in Sweden.

Journal: Acta anaesthesiologica Scandinavica

Published: May 23, 2023

Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial.

Journal: PloS one

Published: April 26, 2023

Population Pharmacokinetics and Dose Evaluation of Cycloserine among Patients with Multidrug-Resistant Tuberculosis under Standardized Treatment Regimens.

Journal: Antimicrobial agents and chemotherapy

Published: April 25, 2023

Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study.

Journal: The Lancet regional health. Europe

Published: November 13, 2022

Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosis.

Journal: Frontiers in pharmacology

Published: August 31, 2022